Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

socalTECH

JANUARY 9, 2014

The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. Avelas Biosciences is developing a flourecent peptide which helps surgeons highlight cancer cells during surgery, specifically for breast cancer. READ MORE>>.

Avalon 138

Avalon San Diego Funding Capital 138

socalTECH

JULY 18, 2013

in venture capital investments in Q2 2013 across Southern California, spread across 80 deals. Those numbers reflected a drop from Q2 of last year, when there was $868.98M in investments across 97 deals. However, venture dollars invested were above Q1, when Southern California saw $569.1M in investments across 90 deals.

Southern California 187

Southern California Venture Capital Tech Coast Angels Capital 187

Xconomy

AUGUST 17, 2016

San Diego’s Avelas Biosciences , founded in 2009 to advance a fluorescing biologic agent intended to help surgeons differentiate cancerous tissue from healthy tissue, has completed a $20 million Series C round of venture funding. and San Diego’s Avalon Ventures. He is the CEO and managing partner at Inbio Ventures.

Avalon 40

Avalon San Diego Study Invest 40

socalTECH

MAY 27, 2014

We are leveraging brand awareness and familiarity, and providing a way for those consumers to help support their families back home. The round was led by Avalon Ventures, and we also had participation from Acciom Venture Lab, a socially responsible venture fund out of Washington, D.C. How did you get into this?

Startup 178

Startup San Diego Avalon Southern California 178

Xconomy

AUGUST 30, 2017

Investment in experimental drugs for hearing loss, long an untapped field in the pharmaceutical industry, may be picking up, but drugs that actually help with these disorders remain elusive.

San Diego 59

San Diego Invest Help Develop 59

Xconomy

JANUARY 26, 2017

As has been the case for biotechs over the past year , insiders helped Anaptys get to the public market. Stockholders who had invested in the. Anaptys also sold 1 million more shares that it had initially planned. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Marketing 40

Marketing San Diego Invest Help 40